Health Care
| Publication of Phase 1 Clinical Trial | 09-Jun-2026 | 07:00 | RNS |
| Commercialisation, Phase II Results & Revenue Path | 05-Jun-2026 | 07:00 | RNS |
| Result of AGM | 03-Jun-2026 | 11:30 | RNS |
| AGM Statement and Business Update | 03-Jun-2026 | 07:00 | RNS |
| AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING | 13-May-2026 | 07:00 | RNS |
| NOTICE OF ANNUAL GENERAL MEETING | 12-May-2026 | 14:24 | RNS |
| KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA | 08-May-2026 | 07:00 | RNS |
| Annual Report for the Year Ended 31 December 2025 | 30-Apr-2026 | 16:18 | RNS |
| Update and IB Nimble Webinar – 27 February... | 11-Feb-2026 | 07:00 | RNS |
| IBAI: Strategic Direction Fueling Organic Growth | 16-Jan-2026 | 07:00 | RNS |
| Expansion Global Distribution Agreement with GE | 10-Dec-2025 | 09:43 | RNS |
| Release of Next-Generation IB Clinic | 26-Nov-2025 | 14:50 | RNS |
| Board Changes | 24-Nov-2025 | 09:56 | RNS |
| Fractional Tumor Burden Mapping Enhances GBM Trial | 13-Nov-2025 | 11:24 | RNS |
| IB Announces Completion of Phase 1 Trial of GaM | 10-Nov-2025 | 15:14 | RNS |
| Currency | UK Pounds |
| Share Price | 0.70p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.20 |
| 52 Week Low | 0.45 |
| Volume | 142,815 |
| Shares Issued | 246.71m |
| Market Cap | £1.73m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:03 | 29,000 @ 0.71p |
| 13:20 | 100,000 @ 0.70p |
| 12:44 | 4,821 @ 0.70p |
| 08:00 | 8,994 @ 0.70p |
You are here: research